Clinical trial
A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The…
NCT00472264 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00472264 |
|---|---|
| Title | A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients |
| Official title | An Exploratory Study To Investigate The Reproducibility Of Lung 18Fluoro-Deoxyglucose Positron Emission Tomography In Patients With Chronic Obstructive Airways Disease (COPD) In The Absence Of Anti-Inflammatory Treatments |
| Lead sponsor | Pfizer, Industry |
| Collaborators | Washington University School of Medicine |
| Status | Terminated |
| Study type | Observational |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Procedure |
| Interventions | PET imaging |
| Enrollment | 20 |
| Start date | May 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | May 11, 2007 |
| Last update posted | Jul 2, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: